44 publications
Name | Date | Type | Actions |
---|---|---|---|
Etats financiers consolidés au 31 décembre 2006 (french) |
10/05/2007 | Annual Report | |
2007 annual earnings Vétoquinol |
19/03/2008 | Annual Report | |
Activity Report 2007 |
19/05/2008 | Annual Report | |
Vétoquinol: H1 2008 interim earnings |
27/08/2008 | Annual Report | |
Rapport semestriel Vétoquinol 2008 (french) Vétoquinol a réalisé de bons résultats au premier semestre 2008 : le chiffre d’affaires |
07/10/2008 | Annual Report | |
2008 Annual earnings Operating highlights |
01/04/2009 | Annual Report | |
2008 activity report |
25/05/2009 | Annual Report | |
Vétoquinol: H1 2009 interim earnings |
01/09/2009 | Annual Report | |
Rapport financier semestriel 2009 (french) Le chiffre d’affaires de Vétoquinol pour le 1er semestre 2009 s’établit à 119,9 M€, en croissance de 2,7% par rapport au premier semestre de l’exercice précédent. |
01/09/2009 | Annual Report | |
2009 Annual earnings 2009 Annual earnings |
01/04/2010 | Annual Report | |
2009 activity report |
21/04/2010 | Annual Report | |
2010 annual earnings Vétoquinol Contents : |
12/04/2011 | Annual Report | |
2010 Activity Report P_06 VÉTOQUINOL’S PROUD HISTORY |
27/04/2011 | Annual Report | |
2011 ANNUAL RESULTS SFAF meeting April 4, 2012 |
05/04/2012 | Annual Report | |
2011 ACTIVITY REPORT Our business: animals. Our advantage: people. |
12/04/2012 | Annual Report | |
2012 ANNUAL RESULTS SFAF Meeting March 27, 2013 |
28/03/2013 | Annual Report | |
Financial statements 2012 1.1CONSOLIDATED FINANCIAL STATEMENTS p.4 |
30/04/2013 | Annual Report | |
Vétoquinol : 80 years striving for animal health worldwide Founded in 1933, Vétoquinol is now a leading global animal health company. |
17/05/2013 | Annual Report | |
2013 annual results SFAF meeting March 13, 2014 |
18/03/2014 | Annual Report | |
2014 annual results Sustained growth, Reference products drive growth in 2014. |
24/03/2015 | Annual Report | |
2015 Annual Results 2015 Annual Results |
22/03/2016 | Annual Report | |
2016 Annual Results Présentation analystes & investisseurs - 23 mars 2017 |
23/03/2017 | Annual Report | |
Présentation des résultats 2016 - french Vétoquinol - 23.03.2017 - 18h15 - Enregistrement Audio Conference |
28/03/2017 | Annual Report | |
2017 Results Investors and Analysts - March 15, 2018 |
15/03/2018 | Annual Report | |
[AUDIO] Présentation des résultats 2017 Présentation analystes & investisseurs - 15 mars 2018 |
22/03/2018 | Annual Report | |
2018 Annual results |
21/03/2019 | Annual Report | |
2019 annual results
|
26/03/2020 | Annual Report | |
[AUDIO] Présentation des résultats 2019 Présentation analystes & investisseurs - 26 mars 2020 |
26/03/2020 | Annual Report | |
Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health. |
08/02/2021 | press release excluding results | |
[VIDEO ]Présentation des résultats 2020 - french Présentation analystes & investisseurs - 1er avril 2021 |
01/04/2021 | Annual Report | |
[AUDIO] Présentation des résultats 2021 Présentation analystes & investisseurs - 24 mars 2022 |
24/03/2022 | Annual Report | |
Annual results 2021 (slideshow) This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022. |
24/03/2022 | Annual Report | |
In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
31/01/2023 | Press releases communication | |
Serving animal Health - 90 years Serving animal Health for over 90 years |
06/03/2023 | Press releases communication | |
ANNUAL RESULTS 2022 (slideshow) 01.2022 Highlights |
23/03/2023 | Annual Report | |
[VIDEO] Présentation des résultats annuels 2022 -French Présentation analystes & investisseurs - 23 Mars 2023 |
23/03/2023 | Annual Report | |
A visionary strategy The key steps of a visionary strategy |
03/04/2023 | Press releases communication | |
Worlds Top 10 The animal health company is firmly established in the world's Top 10. |
27/04/2023 | Press releases communication | |
Essential products Essential products for the most common needs |
27/04/2023 | Press releases communication | |
3rd generation appointed chairman of the board of directors of VETOQUINOL SA At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023. |
25/05/2023 | Press releases communication | |
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
13/06/2023 | Press releases communication | |
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
27/07/2023 | Press releases communication | |
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
13/09/2023 | Press releases communication | |
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights |
20/03/2024 | Annual Report |